Bionano Genomics (BNGO) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Bionano Genomics (BNGO) over the last 6 years, with Q3 2025 value amounting to -$1.59.
- Bionano Genomics' EPS (Weighted Average and Diluted) rose 9485.77% to -$1.59 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.68, marking a year-over-year increase of 9737.92%. This contributed to the annual value of -$88.13 for FY2024, which is 7843.05% up from last year.
- According to the latest figures from Q3 2025, Bionano Genomics' EPS (Weighted Average and Diluted) is -$1.59, which was up 9485.77% from -$1.99 recorded in Q2 2025.
- Bionano Genomics' EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.04 during Q1 2021, with a 5-year trough of -$77.14 in Q4 2023.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$1.24 (2023), whereas its average is -$9.92.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 566797.98% in 2023, then surged by 9678.32% in 2025.
- Quarter analysis of 5 years shows Bionano Genomics' EPS (Weighted Average and Diluted) stood at -$0.08 in 2021, then plummeted by 1512.92% to -$1.34 in 2022, then tumbled by 5667.98% to -$77.14 in 2023, then surged by 79.47% to -$15.83 in 2024, then soared by 89.96% to -$1.59 in 2025.
- Its last three reported values are -$1.59 in Q3 2025, -$1.99 for Q2 2025, and -$1.15 during Q1 2025.